Information 丨 Guangyao Group for the second consecutive year to reach the top 500 in the world, and the ranking reached a new high!

△ Guangyao Group has reached the Fortune 500 in the second consecutive year, and the ranking reached a new high.

On August 3, 2022, this year's Fortune World Fortune 500 list was officially released. It is worth noting that the performance of Guangyao Group is still dazzling and on the list for the second consecutive year. After becoming the first company with Chinese medicine as the main business to enter the Fortune 500 in the world of Fortune last year, this year's ranking reached a new high. The 467th, one by one from last year, has continued to increase its international influence. In the list released by Brand Finance, Guangyao Group ranked 18th in the world's most valuable pharmaceutical brand with a brand value of US $ 2.1 billion, and also increased by 1 from last year. The brand value growth rate ranked first in Chinese pharmaceutical brands Essence

The pharmaceutical and health industry is known as the "never -decaying Chaoyang Industry", and the new crown pneumonia's epidemic is even more concerned about health needs. Guangyao Group has achieved a new breakthrough in the Fortune 500 ranking of Fortune. It is a fruitful fruit that firmly seizes industrial development opportunities and has a forward -looking strategic layout. In order to sustain the advantages of development; adhere to the development of innovation and drive, nearly 200 projects are developed; the construction of the Guangdong -Hong Kong -Macao Greater Bay Area is integrated, set up an international headquarters in Macau, China, and accelerate the international layout ...

As China's largest pharmaceutical enterprise and the largest proprietary pharmaceutical production base, in recent years, the four major business segments of Guangyao Pharmaceutical Group's "Danan Pharmaceutical", "Great Health", "Big Commercial", and "Da Medical" have blossomed, and have achieved high -quality development Essence Li Chuyuan, Secretary of the Party Committee and Chairman of Guangyao Group, said that the next development goal is to create unique industrial characteristics and distinctive world -class biomedical and healthy enterprises.

Grasp the development opportunities of traditional Chinese medicine

"Fashion Chinese Medicine" renewed old name

Guangyao Group has more than 30 subsidiaries, more than half of them, and more than half of the Chinese medicine companies, including 12 Chinese old -fashioned samples, of which 10 have exceeded a century -old history, occupying half of the country's pharmaceutical industry.已有420多年历史并获世界吉尼斯纪录认证的全球最长寿药厂“陈李济”、已有190多年历史并被誉为凉茶始祖的“王老吉”，以及“敬修堂”、“潘高寿”、 "Caizhi Forest" and other enjoyment in the world. In addition, 9 projects under Guangyao Group are also selected as national or provincial traditional Chinese medicine intangible cultural heritage.

Traditional Chinese medicine has been widely recognized in resistance, and has ushered in a new round of development opportunities. After the epidemic occurred, Guangyao Group took the lead in proposing the "two -not -two guarantee" commitment to "do not raise prices, keep working, ensure product quality, and ensure public welfare" to ensure the production and supply of Chinese patent medicines. Health supply line. In addition, it also cooperated with the designated hospitals of the designated hospitals of Xinguan Pneumonia in Guangzhou to cooperate with the eight hospitals affiliated to Guangzhou Medical University to carry out the new drug conversion research of "pneumonia 1", and strive to build it into the first party of the Guangdong -Hong Kong -Macao Greater Bay Area.

The high -quality development of the Chinese medicine industry to support Guangyao Group is a series of "strong base solid" measures -the establishment of 69 standardized planting bases in 69 Chinese medicinal materials nationwide; improve the "standardization, standardization, and information covering the entire life cycle of medicinal materials and slices The "traceability system; participate in the revision of nearly 300 national standards, industry standards, and local standards to promote the modernization and standardization development of Chinese medicine ...

It is worth mentioning that Guangyao Group completed the custody and reorganization of Kangmei Pharmaceutical at the end of last year, and as an industrial investor in Kangmei Pharmaceutical, the latter is the leading brand of Chinese traditional Chinese medicine films. +1 advantages greater than 2. On January 4 this year, Guangyao Group and its listed company Bai Yunshan and Kangmei Pharmaceutical raised 5 million yuan of epidemic prevention materials to support Xi'an, marking the beginning of the cooperation between Guangyao Baiyun Mountain and Kangmei Pharmaceutical. Recently, Li Chuyuan, Secretary of the Party Committee and Chairman of Guangyao Group, also led Guangyao Baiyun Mountain and the Kangmei Pharmaceutical team to go to Beijing Daxing, Jilin, Gansu and other places to explore the new layout of the Chinese medicine industry.

In fact, Guangyao Group has already aimed at the blue ocean of Chinese medicine, continuously explored the various possibilities of integration of traditional Chinese medicine into contemporary life, and proposed the development concept of "fashion Chinese medicine", that is, by using advanced scientific research technology, the current popular young people are easy to accept. Market promotion model to create a healthy product that the general public needs: the epidemic prevention sachet launched during the prevention and control of the epidemic is well received; The research activities of Chinese medicine such as Banlangen "Blue" in the museum, which are widely supported ...

Among them, Wang Laoji, a fashion drink developed with the concept of Chinese medicine "cure disease" and "medicine and food homologous" concept, is a typical representative. Relying on the strong advantages of the "Wang Laoji" brand, in 2019, Guangyao Group developed the pest of Ningji series products with Guizhou Gaowei C fruit thorn pear as raw materials. In 2021, it sold exceeding 1 billion yuan. At present, Guangyao Group has worked on the glorifying Guangdong lychee brand. The 18 litchi deep processing products developed by the "Li Xiaogi" series of products have been launched. He serves as "Guangdong Litchi Industry Public Welfare Ambassador" to help China's rural revitalization cause.

△ With the concept of fashion and health, Guangyao Group has created Wang Laoji, Xingmianji, and Li Xiaoji's "Auspicious Three Treasures".

△ Zhang Hong (middle) served as "Guangdong Litchi Industry Public Welfare Ambassador".

Adhere to scientific and technological innovation

Living the development engine of the pharmaceutical and health industry

Innovation is the source of development. Guangyao Group has established a scientific and technological innovation system covering multiple fields covering Chinese medicine, chemical drugs, raw medicines and medical equipment, continuously increased scientific and technological research and development, and obtained a series of new breakthroughs: its "Hanfang Chinese medicine pharmaceutical process technology and new drugs and new drugs Creation of the National Engineering Research Center "became the only national engineering research center in the field of Chinese medicine in Guangdong Province; the new type of antitumor 1 new drug projects independently developed by the US FDA clinical trial permit; Progress is expected to provide more clinical medication options for the treatment of respiratory diseases; in the face of the epidemic, the "810" scientific and technological engineering has been quickly launched. Carry out scientific research and contribute to the "Guangyao Plan" for resistance to epidemic ... At present, Guangyao Group has a number of global leading innovative drugs research projects, involving anti -tumor, anti -infection, the treatment of immune diseases, treatment of osteocritic inflammation, etc. This pipeline covers a variety of fields such as small molecularized drugs, Chinese medicine, biopharmaceuticals, etc. The entire group is developing nearly 200 projects.

In terms of the construction of the scientific research talent team, Guangyao Group has hired the 1998 Nobel Prize in physiology or medical prize winner Fried Murad as the dean of the Research Institute and the 2006 Nobel Prize winner of the Nobel Dean of the Institute of Medical Devices, the 2013 Nobel Prize in Physiology or Medical Award Landy Shekman as the chief scientist, and has established 3 Nobel Prize winners, 19 domestic academicians and 19 domestic medical masters, foreign experts 7 consultants, high -level talent teams composed of more than 100 doctoral and postdoctoral high -level talents.

In terms of innovation platforms, Guangyao Group has established 8 national scientific research institutions. Among them, the "National Dog Experimental Animal Resource Library" of the General Institute of Guangsi Research Institute has mastered the scientific research strategic resources of the innovative drug research of Beagle Dog. Has an important strategic position in industrial development.

As a leader in the industry, Guangyao Group actively leads the construction, learning, research, research, medical, association (school), and use communication platforms. Following the first biomedicine and health round table summit of the Guangzhou, Hong Kong, Macao Greater Bay Area last year, in June this year, Guangyao Group also hosted the first Chinese medicine prevention and treatment summit forum to gather top academicians and discuss the road to scientific research and innovation in traditional Chinese medicine.

Based on the domestic and international dual -cycle development pattern

Provide a wide range of medicine for the world's health

"International development is the only way for Chinese enterprises to achieve high -quality development." Li Chuyuan said that Guangyao Group took the east wind of the development of the Guangdong -Hong Kong -Macao Greater Bay Area to actively integrate into the dual -cycle development pattern and accelerate the Chinese medicine industry to the world.

The famous "Guangyao Manufacturing" has been selling well overseas for many years, and Huayu Zaizhong Pills of Baiyunshan Qixing has ranked first in the country's proprietary medicine exports for more than ten consecutive years, and entered medical insurance in many countries. Wang Laoji Herbal Tea has registered trademark registration and product exports in more than 150 countries and regions around the world. 701 Battle of town pain cream, Xia Sangju granules, snake gallbladder Sichuan shell liquid, Agai Niuhuang Wan, Dahuang Luo Wan, Baoyun Mountain board Lantan granules and other products are also the main export varieties of Guangzhou Pharmaceutical Group.

In order to accelerate the integration of the international and domestic markets, Guangyao Group has established an international headquarters in Macau. The first landing project is the industrialization of the latest scientific research achievements of Baiyun Mountain Board in Macau in Macau. At present, compound board Lantan granules have obtained the "Pre -Permit for Imported Traditional Drugs" and entered the Macau market. Next, Guangyao Group will focus on creating two new products -1 compound Banlangen's same name, one square medicine, and one new drug of Banlangen, and take the lead in achieving Macau innovation, Macau manufacturing, and sales of Macau. At the end of last year, Guangyao Group built the first GMP standard Chinese medicine factory in Macau. It co -built a joint laboratory with the Chinese Medicine Industry Transformation of the Chinese Medicine Industry with the University of Macau, and accelerated the "Macau Manufacturing" Guangbao famous products to the world.

△ Guang Pharmaceutical Macau International Pharmaceutical Factory.

According to the "Fourteenth Five -Year Plan" strategic development plan of Guangyao Group, in the next five years, Guangyao Group will adhere to the original mission of "improving human health and reducing medical expenses", and is committed to creating world -class biomedical and health enterprises in the world. Health provides a wide range of medicine!

△ Guangyao Baiyunshan Biomedical and Health R & D and sales headquarters design renderings.

※ This article is corporate information, which does not represent the point of view.

- END -